Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Oatly Group AB - ADR (OTLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Oatly Group AB - ADR — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.11 (market cap $4.02B), while Oatly Group AB - ADR trades at $11.1 (market cap $347.84M). The key difference: Edgewise Therapeutics Inc. Common Stock is far larger — about 11.6× Oatly Group AB - ADR's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Oatly Group AB - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Oatly Group AB - ADR for 18 Days on average.
| EWTX | OTLY | |
|---|---|---|
Market Cap | $4.02B | $347.84M |
Volume | 1,446,128 | 116,933 |
Sector | Health | Consumer Staples |
52-Week High | $48.35 | $15.91 |
52-Week Low | $14.89 | $8.03 |
Typical Hold Time | 0 Days | 18 Days |
Enterprise Value | $3.56B | $852.26M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
OTLY trades at $10.88, up 1.97% today, with a bearish technical signal despite a neutral RSI. Revenue grew to $862M in 2025, but net losses persist at -$153M. The company shows improving margins and raised its 2026 revenue outlook after Q2 results. Analyst consensus is mixed with a $12.28 price target, indicating modest upside potential.
The outlook hinges on OTLY's path to profitability amid high debt and negative cash flows. While product innovation and distribution gains offer growth catalysts, the stock faces risks from sustained losses and competitive pressures. Investors should weigh the turnaround progress against financial stability concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Oatly Group AB - ADR
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, Icecreams, among others. It caters to Sweden, Germany, United Kingdom, Netherlands, North America, Finland, and other markets.
Read more on OTLY →
